Kate Therapeutics
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $51M
Investors
- 4
About Kate Therapeutics
Based in California, US, Kate Therapeutics, Inc. operates as a biotechnology research company that develops gene therapies using novel technology platforms. The company was co-founded by Eric Wang and Alan Beggs. As of 2023, the company is headed by its CEO Kevin Forrest. The company offers adeno-associated virus-based gene therapies to treat genetically defined muscle and heart diseases. The firm develops optimal capsid and cargo combinations that aim to treat cardiac as well as muscle disease.
Who invested in Kate Therapeutics
4 investors across 1 round
See all investors in Kate Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 8, 2023
Amount
$51M
Investors
Questions about Kate Therapeutics
Who invested in Kate Therapeutics?
Kate Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kate Therapeutics raised?
Kate Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kate Therapeutics last raise money?
Kate Therapeutics's most recent round on record is a Series A, in Jun 2023.
What does Kate Therapeutics do?
Based in California, US, Kate Therapeutics, Inc.
Where is Kate Therapeutics headquartered?
Kate Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Kate Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kate Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kate Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.